Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2009-12-21
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of fludarabine in treating patients who
have chronic lymphocytic leukemia that has not been previously treated.